… oral corticosteroids stems … inhaled corticosteroids in addition to INCS.15, 16 Despite the
overwhelming evidence that INCS does not lead to an increased risk of glaucoma or cataract …

The aim of this study was to examine whether any correlation exists between long term use
of high doses of inhaled corticosteroids and the occurrence of intraocular hypertension or …

… inhaled steroids (beclomethasone diproprionate) combined with intermittant short reducing
courses of oral steroids. … subcapsular cataracts as a complication of inhaled steroid therapy in …

… In this study, patients were administered increasing doses of inhaled corticosteroids, with or
… on cataract risk among children compared with adults (50). The mechanism(s) behind steroid…

… [1] However, within a few years, in addition to systemic adverse events, a number of
ocular-specific glucocorticoid adverse effects, such as cataract and elevated intraocular pressure (…

… , most commonly cataract and glaucoma1; however, the ocular side effects of inhalational
steroids are less well understood. Intraocular pressure (IOP) is the most common risk factor for …

… determine the prevalence of inhaled steroid-induced glaucoma and cataract in patients with
… to find a dose-related response of steroid-induced cataract and glaucoma in COPD patients. …

… INCSs do not increase the risk of cataracts or glaucoma, although there … inhaled corticosteroids
(ICSs) as a controller medication for asthma concurrently with intranasal corticosteroids (…

… found an increased risk of cataracts. This study … risk of BMD loss, respiratory infection and
cataracts. Further studies are needed to fill this evidence gap, including identifying high risk …

… These data suggest a relatively negligible attributable risk for cataracts associated with ICSs.
However, the population studied was very young, and the results may not be generalizable …